Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Malaria	5/50	1.8221006146977156e-09	1.8221006146977156e-07	178.2888888888889	-399.8172378358562	CSF3;CXCL8;IFNG;IL6;TNF
KEGG_2021_Human	Amoebiasis	5/102	6.972006864965533e-08	1.7430017162413832e-06	82.17525773195877	-227.56322024445333	CXCL8;IFNG;IL6;NOS2;TNF
KEGG_2021_Human	IL-17 signaling pathway	5/94	4.613881700165173e-08	1.7430017162413832e-06	89.65168539325843	-243.34942399375765	CSF3;CXCL8;IFNG;IL6;TNF
KEGG_2021_Human	Chagas disease	5/102	6.972006864965533e-08	1.7430017162413832e-06	82.17525773195877	-227.56322024445333	CXCL8;IFNG;IL6;NOS2;TNF
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	2.911648779163385e-05	74.03703703703704	-172.05130589538587	CXCL8;IL6;NOS2;TNF
KEGG_2021_Human	Rheumatoid arthritis	4/93	3.2795638728842682e-06	5.465939788140447e-05	59.767790262172284	-145.5024915816698	CXCL8;IFNG;IL6;TNF
KEGG_2021_Human	Hematopoietic cell lineage	4/99	4.2131304291399016e-06	6.018757755914145e-05	55.95087719298245	-138.0145897139532	CSF3;FLT3;IL6;TNF
KEGG_2021_Human	African trypanosomiasis	3/37	1.0384632752750053e-05	0.00012980790940937567	101.26890756302521	-158.85054794063166	IFNG;IL6;TNF
KEGG_2021_Human	Pathways in cancer	6/531	1.3121529753006265e-05	0.00013609445164786276	21.55142857142857	-76.68025045813094	AR;CXCL8;FLT3;IFNG;IL6;NOS2
KEGG_2021_Human	Cytokine-cytokine receptor interaction	5/295	1.3609445164786277e-05	0.00013609445164786276	26.820689655172412	-87.5981964107033	CSF3;CXCL8;IFNG;IL6;TNF
KEGG_2021_Human	Graft-versus-host disease	3/42	1.5293149491516165e-05	0.00013902863174105606	88.23076923076923	-143.80928698800247	IFNG;IL6;TNF
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.0002969193042187695	31.349206349206348	-84.54495262531024	CXCL8;IFNG;IL6;TNF
KEGG_2021_Human	Legionellosis	3/57	3.859950954844004e-05	0.0002969193042187695	63.6031746031746	-112.5302356283168	CXCL8;IL6;TNF
KEGG_2021_Human	Tuberculosis	4/180	4.508970382755845e-05	0.0003220693130539889	29.893939393939394	-81.02434645013932	IFNG;IL6;NOS2;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0003629485058995758	55.34101382488479	-100.98537671170521	IFNG;IL6;TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	4/192	5.8071760943932126e-05	0.0003629485058995758	27.94326241134752	-76.22501680035803	CXCL8;FLT3;IL6;MPO
KEGG_2021_Human	Leishmaniasis	3/77	9.524734696085732e-05	0.0005602785115344548	46.2972972972973	-87.57744084010389	IFNG;NOS2;TNF
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.0006750031713836126	22.923976608187136	-63.412309433922275	CSF3;CXCL8;IL6;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0010370307546254617	35.2179675994109	-69.8003308229761	CXCL8;IL6;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	3/100	0.00020740615092509237	0.0010370307546254617	35.2179675994109	-69.8003308229761	CXCL8;IL6;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	3/104	0.0002329673917108638	0.0011093685319564944	33.806223479490804	-67.40758155759835	CXCL8;IL6;TNF
KEGG_2021_Human	HIF-1 signaling pathway	3/109	0.00026769368967035696	0.0012167894985016226	32.19137466307278	-64.6303441766756	IFNG;IL6;NOS2
KEGG_2021_Human	Toxoplasmosis	3/112	0.00029005838446074546	0.0012611234106988931	31.293577981651374	-63.06696788213405	IFNG;NOS2;TNF
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.002186881631125812	25.375266524520256	-52.38188378130509	CXCL8;IL6;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.0030124721930073987	22.31954887218045	-46.57552582678881	CXCL8;IL6;TNF
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.0031726508000862554	21.318059299191376	-44.62403509135876	CXCL8;IL6;TNF
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.0031726508000862554	21.318059299191376	-44.62403509135876	CSF3;IFNG;IL6
KEGG_2021_Human	Allograft rejection	2/38	0.0009469209383415865	0.0033818604940770943	55.77777777777778	-62.87407127134141	IFNG;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.004041009419846262	18.996789727126806	-40.00053498134924	CXCL8;IL6;TNF
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.004041009419846262	48.94512195121951	-56.84526782917664	IFNG;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.004872354663767363	17.394698085419734	-36.72187076283526	CXCL8;IL6;TNF
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.0060713448874818105	15.881401617250674	-33.55383703082171	CXCL8;IL6;TNF
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.0067075893137339086	15.146718146718147	-31.989452913184095	CXCL8;IL6;TNF
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.008448107722012333	30.78076923076923	-39.02900444511024	FLT3;MPO
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.008448107722012333	13.627177700348431	-28.69609856443984	CXCL8;IL6;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.008846831528501218	29.41176470588235	-37.553176952571945	CXCL8;TNF
KEGG_2021_Human	Antigen processing and presentation	2/78	0.003939415117888246	0.010647067886184448	26.289473684210527	-34.099339569929285	IFNG;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.013716711464764891	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.014547848269579158	21.67391304347826	-28.742216935482162	IFNG;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.016443808162300667	19.524509803921568	-26.130280011490946	CXCL8;TNF
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.016443808162300667	19.524509803921568	-26.130280011490946	IFNG;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.016443808162300667	19.524509803921568	-26.130280011490946	IL6;TNF
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.01688835503581254	18.778301886792452	-25.204052222837845	IL6;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.01688835503581254	18.95952380952381	-25.42995427691617	IFNG;IL6
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.017332730990677423	9.422466422466423	-19.140881053489387	CSF3;FLT3;IL6
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.017332730990677423	18.086363636363636	-24.33571316400054	IL6;TNF
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.018987350735525835	9.018735362997658	-18.187178129854335	IL6;NOS2;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.021169425662567846	15.886	-21.510038502238015	IFNG;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.022011305497085135	15.385658914728682	-20.853034219946885	IFNG;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.022853196480921375	14.915413533834586	-20.230385574789178	IFNG;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.023694809987592727	14.472627737226277	-19.639406588988233	IFNG;TNF
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.0287678656573896	12.762903225806452	-17.312716751580805	IFNG;TNF
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.0287678656573896	12.847402597402597	-17.429441058365175	CXCL8;IL6
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.02892312444914933	12.597133757961783	-17.083187709957596	IFNG;TNF
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.03231302968466593	6.897094430992736	-13.07371705691191	IL6;NOS2;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.036026518825980396	6.556709956709956	-12.239051897711217	IFNG;IL6;TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.03951854378025758	10.31020942408377	-13.840129933766221	CXCL8;IL6
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.04230102684912506	9.835	-13.147442958027579	IL6;TNF
KEGG_2021_Human	Arginine biosynthesis	1/22	0.026917919418171	0.04562359223418814	42.576719576719576	-21.34946103825324	NOS2
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.04754406820317318	9.044930875576037	-11.980722307867735	IL6;TNF
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.05799092383407311	8.01639344262295	-10.432967830507518	CXCL8;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.06087180958017624	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.06795490457294803	7.192804428044281	-9.169844698845731	IL6;TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07636689287009554	6.657534246575342	-8.337786615237395	FLT3;TNF
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.07636689287009554	22.3	-12.692261742471414	CXCL8
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.08289203699696278	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Proteasome	1/46	0.05553766478796506	0.08289203699696278	19.809876543209878	-11.46289716991079	IFNG
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.08512955276204585	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Arginine and proline metabolism	1/50	0.060233261208856796	0.0872945814621113	18.183673469387756	-10.63265628196324	NOS2
KEGG_2021_Human	Amyotrophic lateral sclerosis	2/364	0.07172754804182349	0.10246792577403356	5.321823204419889	-6.226988268408014	NOS2;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.10612564172503353	14.347670250896057	-8.574814690072902	IL6
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11119679502513437	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.11119679502513437	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Central carbon metabolism in cancer	1/70	0.08339759626885078	0.11119679502513437	12.880837359098228	-7.74542097629872	FLT3
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.11119679502513437	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	Peroxisome	1/82	0.09704826642438931	0.12769508740051225	10.956104252400548	-6.615247747466243	NOS2
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.13626804630200867	10.075757575757576	-6.080768259179883	IFNG
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.13706804751856888	9.739926739926739	-5.8737398650795125	IFNG
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.13706804751856888	9.739926739926739	-5.8737398650795125	NOS2
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.14056071798047778	9.226851851851851	-5.553951626329874	AR
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.14056071798047778	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Drug metabolism	1/108	0.12599902727061665	0.15365735033002031	8.2668743509865	-4.943743954376122	MPO
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16625766728927005	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.17502291251662846	6.892361111111111	-4.041189892105298	NOS2
KEGG_2021_Human	Oocyte meiosis	1/129	0.1487694756391342	0.17502291251662846	6.892361111111111	-4.041189892105298	AR
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.1754767358985943	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.1808074831472303	6.480392156862745	-3.763669230249352	NOS2
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.18116329984793467	6.384863123993559	-3.698840756963446	IL6
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.18269267949762263	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.18767748038744303	5.987150415721844	-3.427000500776257	CXCL8
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.19021399129376276	5.82560706401766	-3.3156870475343334	MPO
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19041316430803393	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22679173345559608	4.657210401891253	-2.4954112144854435	MPO
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.22756764688826345	4.5823152995927865	-2.441961042053517	CXCL8
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23871972129514	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.243369765545461	4.137440758293839	-2.12256354972075	TNF
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.260731901994932	3.7696007696007694	-1.8563524399324505	FLT3
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.26312824115394423	3.6554621848739495	-1.7734497985532327	AR
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.26312824115394423	3.6397024639702464	-1.7619943041292825	NOS2
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3420488957114324	2.6053872053872054	-1.0106876845884132	TNF
